American and Canadian life science division of Merck KGaA, MilliporeSigma, is set to pay out some USD 300 million to boost biosafety testing at its manufacturing site in Rockville, MD. The new facility expansion, the largest investment in contract testing in the company's history, will extend its capacity for biosafety testing, analytical development, viral clearance suites and services for cell bank manufacturing.